As of 2025-09-18, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 42.61 USD. This relative valuation is based on P/E multiples. With the latest stock price at 75.18 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -43.3%.
The range of the Relative Valuation is 31.25 - 52.06 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.0x - 39.9x | 35.2x |
| Forward P/E multiples | 20.6x - 34.3x | 26.7x |
| Fair Price | 31.25 - 52.06 | 42.61 |
| Upside | -58.4% - -30.8% | -43.3% |
| Date | P/E |
| 2025-09-18 | 61.07 |
| 2025-09-17 | 59.27 |
| 2025-09-16 | 56.23 |
| 2025-09-15 | 54.82 |
| 2025-09-12 | 57.45 |
| 2025-09-11 | 58.60 |
| 2025-09-10 | 56.46 |
| 2025-09-09 | 56.55 |
| 2025-09-08 | 56.16 |
| 2025-09-05 | 54.68 |
| 2025-09-04 | 54.69 |
| 2025-09-03 | 56.24 |
| 2025-09-02 | 56.27 |
| 2025-08-29 | 54.97 |
| 2025-08-28 | 54.86 |
| 2025-08-27 | 54.97 |
| 2025-08-26 | 54.85 |
| 2025-08-25 | 54.26 |
| 2025-08-22 | 55.45 |
| 2025-08-21 | 55.96 |
| 2025-08-20 | 55.50 |
| 2025-08-19 | 55.34 |
| 2025-08-18 | 56.57 |
| 2025-08-15 | 56.56 |
| 2025-08-14 | 56.76 |
| 2025-08-13 | 57.39 |
| 2025-08-12 | 58.02 |
| 2025-08-11 | 56.74 |
| 2025-08-08 | 57.00 |
| 2025-08-07 | 56.35 |
| 2025-08-06 | 55.60 |
| 2025-08-05 | 55.54 |
| 2025-08-04 | 56.58 |
| 2025-08-01 | 54.40 |
| 2025-07-31 | 52.96 |
| 2025-07-30 | 55.12 |
| 2025-07-29 | 53.77 |
| 2025-07-28 | 54.52 |
| 2025-07-25 | 53.84 |
| 2025-07-24 | 53.29 |
| 2025-07-23 | 53.92 |
| 2025-07-22 | 54.46 |
| 2025-07-21 | 55.28 |
| 2025-07-18 | 55.86 |
| 2025-07-17 | 57.63 |
| 2025-07-16 | 57.43 |
| 2025-07-15 | 56.30 |
| 2025-07-14 | 57.37 |
| 2025-07-11 | 56.67 |
| 2025-07-10 | 56.77 |